Expression of PLK1 and survivin in diffuse large B-cell lymphoma

Leukemia and Lymphoma

Volumn 48, Issue 11, 2007, Pages 2179-2183

  Liu, Lin ^a   Zhang, Min ^a   Zou, Ping ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Diffuse large B cell lymphoma; Polo like kinase 1; Prognosis; Survivin

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; LACTATE DEHYDROGENASE; POLO LIKE KINASE 1; PREDNISONE; SURVIVIN; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; IMMUNOHISTOCHEMISTRY; LACTATE DEHYDROGENASE BLOOD LEVEL; LARGE CELL LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REGRESSION ANALYSIS; SURVIVAL TIME; SYMPTOM;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CELL CYCLE PROTEINS; CHILD; CHILD, PRESCHOOL; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; SURVIVAL ANALYSIS;

EID: 36049033181     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701615918     Document Type: Article

References (32)

1. Paepe, D. P. and Wolf-Peeters, D. C. (2007) Diffuse large B-cell lymphoma: A heterogeneous group of non-Hodgkin lymphomas comprising several distinct clinicopathological entities. Leukemia, 21, pp. 37-43.
2. Rossi, D. and Gaidano, G. (2002) Molecular heterogeneity of diffuse large B-cell lymphoma: Implications for disease management and prognosis. Hematology, 7, pp. 239-252.
3. Lossos, I. S. and Morgensztern, D. (2006) Prognostic biomarkers in diffuse large B-cell lymphoma. J Clin Oncol, 24, pp. 995-1007.
4. Evan, G. I. and Vousden, K. H. (2001) Proliferation, cell cycle and apoptosis in cancer. Nature, 411, pp. 342-348.
5. Dai, W., Wang, Q. and Traganos, F. (2002) Polo-like kinases and centrosome regulation. Oncogene, 21, pp. 6195-6200.
6. McInnes, C., Mazumdar, A., Mezna, M., Meades, C., Midgley, C. and Scaerou, F. (2006) Inhibitors of polo-like kinase reveal roles in spindle-pole maintenance. Nat Chem Biol, 2, pp. 608-617.
7. van de Weerdt, B. C., van Vugt, M. A., Lindon, C., Kauw, J. J., Rozendaal, M. J. and Klompmaker, R. (2005) Uncoupling anaphase-promoting complex/cyclosome activity from spindle assembly checkpoint control by deregulating polo-like kinase 1. Mol Cell Biol, 25, pp. 2031-2044.
8. Zhou, T., Aumais, J. P., Liu, X., Yu-Lee, L. Y. and Erikson, R. L. (2003) A role for Plk1 phosphorylation of NudC in cytokinesis. Dev Cell, 5, pp. 127-138.
9. Shin, S., Sung, B. J., Cho, Y. S., Kim, H. J., Ha, N. C. and Hwang, J. I. (2001) An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry, 40, pp. 1117-1123.
10. Eckerdt, F., Yuan, J. and Strebhardt, K. (2005) Polo-like kinases and oncogenesis. Oncogene, 24, pp. 267-276.
11. Duffy, M. J., O'Donovan, N., Brennan, D. J., Gallagher, W. M. and Ryan, B. M. (2007) Survivin: A promising tumor biomarker. Cancer Lett
12. Sah, N. K., Khan, Z., Khan, G. J. and Bisen, P. S. (2006) Structural, functional and therapeutic biology of survivin. Cancer Lett, 244, pp. 164-171.
13. Weichert, W., Denkert, C., Schmidt, M., Gekeler, V., Wolf, G. and Kobel, M. (2004) Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma. Br J Cancer, 90, pp. 815-821.
14. Keating, A. (2006) Biomarkers of potential prognostic significance in diffuse large B-cell lymphoma. Cancer, 106, pp. 247-257.
15. Lowery, D. M., Lim, D. and Yaffe, M. B. (2005) Structure and function of polo-like kinases. Oncogene, 24, pp. 248-259.
16. Smith, M. R., Wilson, M. L., Hamanaka, R., Chase, D., Kung, H. and Longo, D. L. (1997) Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinase. Biochem Biophys Res Commun, 234, pp. 397-405.
17. Wolf, G., Elez, R., Doermer, A., Holtrich, U., Ackermann, H. and Stutte, H. J. (1997) Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer. Oncogene, 14, pp. 543-549.
18. Knecht, R., Elez, R., Oechler, M., Solbach, C., von Ilberg, C. and Strebhardt, K. (1999) Prognostic significance of polo-like kinase (PLK) expression in squamous cell carcinomas of the head and neck. Cancer Res, 59, pp. 2794-2797.
19. Tokumitsu, Y., Mori, M., Tanaka, S., Akazawa, K., Nakano, S. and Niho, Y. (1999) Prognostic significance of polo-like kinase expression in esophageal carcinoma. Int J Oncol, 15, pp. 687-692.
20. Kanaji, S., Saito, H., Tsujitani, S., Matsumoto, S., Tatebe, S. and Kondo, A. (2006) Expression of polo-like kinase 1 (PLK1) protein predicts the survival of patients with gastric carcinoma. Oncology, 70, pp. 126-133.
21. Takai, N., Miyazaki, T., Fujisawa, K., Nasu, K., Hamanaka, R. and Miyakawa, I. (2001) Expression of polo-like kinase in ovarian cancer is associated with histological grade and clinical stage. Cancer Lett, 164, pp. 41-49.
22. Takai, N., Miyazaki, T., Fujisawa, K., Nasu, K., Hamanaka, R. and Miyakawa, I. (2001) Polo-like kinase (PLK) expression in endometrial carcinoma. Cancer Lett, 169, pp. 41-49.
23. Takahashi, T., Sano, B., Nagata, T., Kato, H., Sugiyama, Y. and Kunieda, K. (2003) Polo-like kinase 1 (PLK1) is overexpressed in primary colorectal cancers. Cancer Sci, 94, pp. 148-152.
24. Wolf, G., Hildenbrand, R., Schwar, C., Grobholz, R., Kaufmann, M. and Stutte, H. J. (2000) Polo-like kinase: A novel marker of proliferation: correlation with estrogen-receptor expression in human breast cancer. Pathol Res Pract, 196, pp. 753-759.
25. Kneisel, L., Strebhardt, K., Bernd, A., Wolter, M., Binder, A. and Kaufmann, R. (2002) Expression of polo-like kinase (PLK1) in thin melanomas: A novel marker of metastatic disease. J Cutan Pathol, 29, pp. 354-358.
26. Weichert, W., Schmidt, M., Gekeler, V., Denkert, C., Stephan, C. and Jung, K. (2004) Polo-like kinase 1 is overexpressed in prostate cancer and linked to higher tumor grades. Prostate, 60, pp. 240-245.
27. Ito, Y., Miyoshi, E., Sasaki, N., Kakudo, K., Yoshida, H. and Tomoda, C. (2004) Polo-like kinase 1 overexpression is an early event in the progression of papillary carcinoma. Br J Cancer, 90, pp. 414-418.
28. Knecht, R., Oberhauser, C. and Strebhardt, K. (2000) PLK (polo-like kinase), a new prognostic marker for oropharyngeal carcinomas. Int J Cancer, 89, pp. 535-536.
29. Wheatley, S. P. and McNeish, I. A. (2005) Survivin: A protein with dual roles in mitosis and apoptosis. Int Rev Cytol, 247, pp. 35-88.
30. Altieri, D. C. (2003) Survivin in apoptosis control and cell cycle regulation in cancer. Prog Cell Cycle Res, 5, pp. 447-452.
31. Adida, C., Haioun, C., Gaulard, P., Lepage, E., Morel, P. and Briere, J. (2000) Prognostic significance of survivin expression in diffuse large B-cell lymphomas. Blood, 96, pp. 1921-1925.
32. Mito, K., Kashima, K., Kikuchi, H., Daa, T., Nakayama, I. and Yokoyama, S. (2005) Expression of polo-like kinase (PLK1) in non-Hodgkin's lymphomas. Leuk Lymphoma, 46, pp. 225-231.